Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127707401 | 12770740 | 1 | I | 20151223 | 20160908 | 20160922 | 20160922 | EXP | US-PFIZER INC-2016440063 | PFIZER | 76.00 | YR | F | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127707401 | 12770740 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | Oral | U | 73676 | TABLET | |||||||||
| 127707401 | 12770740 | 2 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | U | U | 19999 | |||||||||
| 127707401 | 12770740 | 3 | SS | TAGRISSO | OSIMERTINIB | 1 | Oral | 80 MG, 1X/DAY | Y | 0 | 80 | MG | QD | ||||||
| 127707401 | 12770740 | 4 | SS | TAGRISSO | OSIMERTINIB | 1 | Oral | UNK | Y | 0 | |||||||||
| 127707401 | 12770740 | 5 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | ||||||||||
| 127707401 | 12770740 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127707401 | 12770740 | 7 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127707401 | 12770740 | 8 | C | EXCEDRIN TENSION HEADACHE | ACETAMINOPHENCAFFEINE | 1 | 0 | ||||||||||||
| 127707401 | 12770740 | 9 | C | TRIAMTERENE. | TRIAMTERENE | 1 | 0 | ||||||||||||
| 127707401 | 12770740 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127707401 | 12770740 | 11 | C | SAME ADENOSYS L METHIONINE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127707401 | 12770740 | 2 | Pain |
| 127707401 | 12770740 | 3 | Lung carcinoma cell type unspecified stage 0 |
| 127707401 | 12770740 | 6 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127707401 | 12770740 | OT |
| 127707401 | 12770740 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127707401 | 12770740 | Abdominal discomfort | |
| 127707401 | 12770740 | Cancer pain | |
| 127707401 | 12770740 | Chest discomfort | |
| 127707401 | 12770740 | Constipation | |
| 127707401 | 12770740 | Cough | |
| 127707401 | 12770740 | Decreased appetite | |
| 127707401 | 12770740 | Dehydration | |
| 127707401 | 12770740 | Diarrhoea | |
| 127707401 | 12770740 | Dysgeusia | |
| 127707401 | 12770740 | Dysphagia | |
| 127707401 | 12770740 | Dysphonia | |
| 127707401 | 12770740 | Dyspnoea | |
| 127707401 | 12770740 | Fatigue | |
| 127707401 | 12770740 | Muscular weakness | |
| 127707401 | 12770740 | Nausea | |
| 127707401 | 12770740 | Ocular discomfort | |
| 127707401 | 12770740 | Pleural effusion | |
| 127707401 | 12770740 | Pneumonia | |
| 127707401 | 12770740 | Skin atrophy | |
| 127707401 | 12770740 | Skin burning sensation | |
| 127707401 | 12770740 | Swelling | |
| 127707401 | 12770740 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127707401 | 12770740 | 3 | 20151223 | 0 |